All news and updates from MAGic Bioprocessing
Mats Johnson enter as new chairman of the board of directors
Posted on Friday 3 July 2020
We welcome Mats Johnson, former CEO at Bio-Works, as the new chairman of the board of directors.
Mats has almost 40 years of experience from the life science area in biotech supply, drug discovery and genetic modifications of plants mainly in different business positions but also from R&D with the companies Pharmacia Biotech, Amersham Biosciences, SweTree Technologies and Bio-Works Technologies. In the last two companies Mats was CEO, all-in-all, for almost 15 years. SweTree was brought to profitability and Bio-Works was built to an IPO, with relevant industrial structures and global market access. Mats has during the last 15 years been instrumental in finding financing of almost 500 MSEK for SweTree, its spin-outs and Bio-Works.
New members to the board of directors
Posted on Friday 5 June 2020
We welcome Kristina Köhler, Pär Nordström and Mats Ekholm as new members to the Board of Directors. They were elected as new board members on the Annual General Meeting of shareholders on the 28th of May.
Kristina is a senior leader with extensive experience in biopharmaceutical development and industrialization from Sobi and its predecessors.
Pär is an experienced venture capitalist and was the first non-founder shareholder in the company.
Mats has a background as engineer from Scanditronix and is now CEO at Uppsala Cementgjuteri who is an important venture capitalist in the Uppsala region.
MAGic Bioprocessing receives funding from VINNOVA
Posted on Wednesday 27 May 2020
MAGic Bioprocessing has received a 400 000 SEK grant from Vinnova, Swedens Innovation Agency. The grant has been provided within the program Competence Centers; support for SME´s 2020. The funding will be used during 2020 to develop and test magnetic beads for the purification of monoclonal antibodies, recombinant proteins and cells. The project will be conducted in collaboration with the Cell Technology Group (CETG) at the Royal Institute of Technology in Stockholm (KTH).
MAGic Bioprocessing is a member of the competence center of Advanced BioProduction (AdBioPro) Vinnova 2016-05181 which is coordinated by KTH. AdBioPro aims to developing competitive technology for bioproduction, focusing on the imminent paradigm shift towards continuous processes of biopharmaceuticals, and on manufacturing of emerging potent therapeutic products such as recombinant viral vector and cell products. Read more about AdBioPro here
TOP 10% most downloaded paper
Posted on Wednesday 27 May 2020
We are excited to share that our research published in the journal Biotechnology Progress is among the top 10% most downloaded papers during 2018-2019.
The paper with the title Pilot‐scale process for magnetic bead purification of antibodies directly from non‐clarified CHO cell culture shows the beneficials of using magnetic bead-based processes for the capture and recovery of biologics compared to the traditional column chromatography process. Our research explore the possibilities to perform purification in the prescence of cells in larger feedstocks. The research is conducted in collaboration with the Cell Technology Group (CETG) at the Royal Institute of Technology in Stockholm (KTH).